OhioHealth

Columbus, Ohio 43228

10 studies enrolling now · 51 studies all time

What they study most

ALS, Acute Coronary Syndrome, Acute Decompensated Heart Failure, Acute Heart Failure, Acute Ischemic Stroke, Amyotrophic Lateral Sclerosis, Aortic Insufficiency, Aortic Regurgitation, Aortic Valve Insufficiency, Aortic Valve Stenosis, Arrhythmias, Cardiac, Arterial Insufficiency

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer — Recruiting now
• Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI) — Recruiting now
• ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™ — Recruiting now
• A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma — Recruiting now
• A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM) — Recruiting now
• A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3) — Recruiting now
• A Global Study of the PETAL Consortium — Recruiting now
• Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study — Recruiting now
• Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System — Recruiting now
• Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic Adenocarcinoma — Available (expanded access)
• Hypofractionated vs. Conventional Regional Nodal Radiation Therapy for Patients With Invasive Breast Cancer — Running, not enrolling
• A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2) — Running, not enrolling
• Study in Parkinson Disease of Exercise — Running, not enrolling
• Middle Meningeal Artery Embolization for the Treatment of Subdural Hematomas With TRUFILL® n-BCA — Completed
• A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination — Paused
• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
• Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS) — Completed
• SPHERE Per-AF Post-Approval Study — Running, not enrolling
• A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment — Running, not enrolling
• A Prospective Single-Arm Multicenter StuDy of the BarE TEmporary SPur StEnt System foR the tREatment of Vascular Lesions Located in the infrapoplitEal Arteries beLow the Knee (DEEPER REVEAL) — Completed
• AI Powered Mapping Technology for Identifying Arrhythmias — Completed
• A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS) — Running, not enrolling
• Multi-Center Project: Building Electronic Tools To Enhance and Reinforce CArdiovascular REcommendations - Heart Failure — Completed
• Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis — Running, not enrolling
• Addressing Under-treatment and Health Equity in AS and MR Using an Integrated EHR Platform — Completed
• Single Fraction or Multi-fraction Palliative Radiation Therapy for the Improvement of Quality of Life in Patients With Metastatic Gynecologic Cancers — Running, not enrolling
• IS-001 Injection in Patients Undergoing Robotic-Assisted Gynecological Surgery — Completed
• Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors — Stopped early
• Evaluate the Efficacy & Safety of Leronlimab in Patients With Severe or Critical COVID-19 — Completed
• Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care — Completed
• SVC Occlusion in Subjects With Acute Decompensated Heart Failure — Completed
• Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS — Running, not enrolling
• Long-term Extension to Study AC-058B301 to Investigate Safety, Tolerability and Disease Control of Ponesimod 20 mg in Patients With Relapsing Multiple Sclerosis — Completed
• CERENOVUS Neurothrombectomy Devices Registry — Completed
• A Second Intermediate-Size Expanded Access Protocol (EAP) for Pridopidine in People With Amyotrophic Lateral Sclerosis (Pridopidine EAP 2) — NO_LONGER_AVAILABLE
• FlowMet-R Blood Flow Measurement for the Diagnosis of Peripheral Artery Disease and Critical Limb Ischemia — Stopped early
• A Randomized, Controlled Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System (SUMMIT MAX) — Completed
• Prematurity Risk Assessment Combined With Clinical Interventions for Improving Neonatal outcoMEs — Running, not enrolling
• Safety and Efficacy of the Noxsano Wound Care Bandage — Stopped early
• Observational Study to Evaluate PAD Treatment Clinical and Economic Outcomes — Completed
• Happy, Healthy, Loved: A Mobile-delivered Breastfeeding Self-efficacy Intervention for First Time Parents — Completed
• REDUCE LAP-HF RANDOMIZED TRIAL I — Running, not enrolling
• REDUCE LAP-HF TRIAL II — Running, not enrolling
• Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19 — Completed
• KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC — Stopped early
• Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer — Status unconfirmed
• Tolerability of Acthar for the Treatment of Multiple Sclerosis in Relapses (TAMS) — Completed
• Caisson Transcatheter Mitral Valve Replacement (TMVR) System Early Feasibility Study — Status unconfirmed
• POSITIVE Stroke Clinical Trial — Stopped early
• A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries. — Completed